KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
FRA:YMP3
Delisted

Symphony Holdings Limited Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
0.0890€
+0 (+0%)
At Close: Aug 17, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 0.0890€ 0.0890€ Wednesday, 17th Aug 2022 YMP3.F stock ended at 0.0890€. During the day the stock fluctuated 0% from a day low at 0.0890€ to a day high of 0.0890€.
90 days 0.0890€ 0.0890€
52 weeks 0.0890€ 0.0905€

Historical Symphony Holdings Limited prices

Date Open High Low Close Volume
Feb 21, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 18, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 17, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 16, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 15, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 14, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 11, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 10, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 09, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 08, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 07, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 04, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 03, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 02, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Feb 01, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Jan 31, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Jan 28, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Jan 27, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Jan 26, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Jan 25, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Jan 24, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Jan 21, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Jan 20, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Jan 19, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Jan 18, 2022 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Click to get the best stock tips daily for free!

About Symphony Holdings Limited

Symphony Holdings Limited Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... YMP3.F Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT